Dr. Dubin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1549 Tanglewood Dr
West Chester, PA 19380Phone+1 610-651-0827- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 1989 - 1991
- University of ColoradoResidency, Internal Medicine, 1983 - 1986
- Perelman School of Medicine at the University of PennsylvaniaClass of 1983
Certifications & Licensure
- PA State Medical License 1987 - 2024
- CO State Medical License 1985 - 1989
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 5 citationsSerologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysisHtay Htay Han, Naveen Karkada, Girish Jayadeva, Gary Dubin> ;Human Vaccines & Immunotherapeutics. 2017 Jan 2
- 68 citationsPrior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-h...Suzanne M. Garland, Jorma Paavonen, Unnop Jaisamrarn, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Dan Apter, Xavier Castellsagué, Julio Cesar Teixeira, S. Rachel Skinne...> ;International Journal of Cancer. 2016 Dec 15
- 20 citationsSafety of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in adolescents aged 12–15 years: Interim analysis of a large community-randomized controlled trialMatti Lehtinen, Tiina Eriksson, Dan Apter, Mari Hokkanen, Kari Natunen, Jorma Paavonen, Eero Pukkala, Maria-Genalin Angelo, Julia Zima, Marie-Pierre David, Sanjoy K Da...> ;Human Vaccines & Immunotherapeutics. 2016 Nov 14
- Join now to see all
Press Mentions
- Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union | Pages DaDecember 8th, 2022
- Takeda Dengue Vaccine Recommended for Approval by European CommitteeOctober 17th, 2022
- Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic CountriesOctober 14th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: